Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

Bloomberg Reports Debate over Zyn Nicotine Raises Controversy

Business by 2FIRSTS.ai
Jan.31.2024
Bloomberg Reports Debate over Zyn Nicotine Raises Controversy
Senate Majority Leader Chuck Schumer has urged federal officials to investigate the nicotine pouch brand Zyn, sparking debate on nicotine-related issues.

On January 31, Bloomberg reported that Senate Majority Leader Chuck Schumer has called on federal officials to investigate the controversy surrounding Zyn, a nicotine pouch brand owned by Philip Morris International. This has sparked a debate on nicotine-related issues.

 

Right-wing lawmakers have responded in droves, criticizing the Democratic Party's excessive intervention and calling for a "Zyn uprising," borrowing from Texas' historical slogan of "come and take it." This issue has already surfaced in campaign ads for the 2024 elections and has become a topic of a bipartisan bill in the House of Representatives this week.

 

References:
[1] Smokeless Nicotine Zyn Sparks Culture War Fight for Schumer, GOP
Also Read:
[1] Growing Global Nicotine Pouch Market Predicted to Reach $23.6 Billion by 2030
[2] Imperial Brand Teams Up with Racing Team for Sponsorship
#North America#United States#Legislation#Nicotine-free e-cigarettes#Nicotine e-cigarettes#Nicotine-containing e-cigarettes#British American Tobacco (BAT)#Report#ZYN

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

INTER-TABAC
INTER-TABAC
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
The 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) will be held in Geneva, Switzerland, from November 7 to 22, 2025. The meeting is expected to focus on the disclosure of tobacco constituents, environmental impacts, and industry responsibility. South Korea plans to implement the Tobacco Harmfulness Management Act in November and is preparing to send a delegation to COP11 to help align domestic regulations with international standards.
Sep.05 by 2FIRSTS.ai
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Technology Inc. (NASDAQ: ISPR) announced its financial results for the fiscal year ending June 30, 2025, on September 16, 2025. The report showed that the company's operating revenue was $127.5 million, down from $151.9 million in the previous fiscal year. Gross profit decreased from $29.8 million to $22.6 million, with gross profit margin falling from 19.6% to 17.8%. Net loss widened from $14.8 million to $39.2 million.
Sep.17 by 2FIRSTS.ai
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac concluded successfully under the theme “From Change to Opportunity,” focusing on the global harm-reduction landscape, shifts in the U.S. market, dynamics in China’s supply chain, vaping product trends, and capital-market opportunities. 2Firsts International Editor-in-Chief Taco Tuinstra, compliance expert Kurt Yang, co-founder Echo Guo, and CEO Alan Zhao shared frontline insights, drawing on UK MHRA registration data and China customs export data to present a compreh
Sep.20
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
Products | "Pod Mod Surge" Accelerates Post-Disposable Ban as VOZOL Launches New Pod System in the UK
Products | "Pod Mod Surge" Accelerates Post-Disposable Ban as VOZOL Launches New Pod System in the UK
After the disposable vape ban took effect, updates to the pod category in the UK's MHRA database surged, showing that the market is rapidly pivoting to reusable pod systems. Against this backdrop, 2FIRSTS observed that VOZOL also recently launched a new pod product in the UK, which this article will examine in detail.
Aug.28 by 2FIRSTS.ai
Related Topics
News Company
Related Read
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
2FIRSTS.ai
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
2FIRSTS.ai
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
2FIRSTS.ai
Products | "Pod Mod Surge" Accelerates Post-Disposable Ban as VOZOL Launches New Pod System in the UK
Products | "Pod Mod Surge" Accelerates Post-Disposable Ban as VOZOL Launches New Pod System in the UK
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文